Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 7.


Bonanno, Patricia Vella, Ermisch, Michael, Godman, Brian ORCID: 0000-0001-6539-6972, Martin, Antony P ORCID: 0000-0003-4383-6038, Van den Bergh, Jesper, Bezmelnitsyna, Liudmila, Bucsics, Anna, Arickx, Francis, Bybau, Alexander, Bochenek, Tomasz
et al (show 28 more authors) (2017) Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation. FRONTIERS IN PHARMACOLOGY, 8.


Godman, Brian ORCID: 0000-0001-6539-6972, Bucsics, Anna, Bonanno, Patricia Vella, Oortwijn, Wija, Rothe, Celia C, Ferrario, Alessandra, Bosselli, Simone, Hill, Andrew, Martin, Antony P ORCID: 0000-0003-4383-6038, Simoens, Steven
et al (show 42 more authors) (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. FRONTIERS IN PUBLIC HEALTH, 6.


Godman, Brian, McCabe, Holly, Leong, Trudy D, Mueller, Debjani, Martin, Antony P ORCID: 0000-0003-4383-6038, Hoxha, Iris, Mwita, Julius C, Rwegerera, Godfrey Mutashambara, Massele, Amos, Costa, Juliana de Oliveira
et al (show 45 more authors) (2020) Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 20 (1). 1 - 26.


Ferrario, Alessandra, Araja, Diana, Bochenek, Tomasz, Catic, Tarik, Danko, David, Dimitrova, Maria, Furst, Jurij, Greiciute-Kuprijanov, Ieva, Hoxha, Iris, Jakupi, Arianit
et al (show 14 more authors) (2017) The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. PHARMACOECONOMICS, 35 (12). 1271 - 1285.


Godman, Brian ORCID: 0000-0001-6539-6972, Hill, Andrew, Simoens, Steven, Kurdi, Amanj, Gulbinovič, Jolanta, Martin, Antony P ORCID: 0000-0003-4383-6038, Timoney, Angela, Gotham, Dzintars, Wale, Janet, Bochenek, Tomasz
et al (show 38 more authors) (2019) Pricing of oral generic cancer medicines in 25 European countries; fi ndings and implications. Generics and Biosimilars Initiative Journal, 8 (2). 49 - 70.


Bonanno, Patricia Vella, Bucsics, Anna, Simoens, Steven, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Gulbinovic, Jolanta, Rothe, Celia, Timoney, Angela, Ferrario, Alessandra, Gad, Mohamed
et al (show 26 more authors) (2019) Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 19 (3). 251 - 261.


Pontes, Caridad, Zara, Corinne, Torrent-Farnell, Josep, Obach, Merce, Nadal, Cristina, Vella-Bonanno, Patricia, Ermisch, Michael, Simoens, Steven, Hauegen, Renata Curi, Gulbinovic, Jolanta
et al (show 13 more authors) (2020) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 18 (1). 5 - 16.

This list was generated on Sun Nov 29 06:10:19 2020 GMT.